Compare ELV & RCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELV | RCL |
|---|---|---|
| Founded | 1944 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.6B | 81.6B |
| IPO Year | 2001 | 1997 |
| Metric | ELV | RCL |
|---|---|---|
| Price | $399.10 | $292.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 18 |
| Target Price | ★ $383.56 | $353.44 |
| AVG Volume (30 Days) | 942.4K | ★ 1.8M |
| Earning Date | 04-22-2026 | 04-30-2026 |
| Dividend Yield | 1.83% | ★ 2.36% |
| EPS Growth | N/A | ★ 42.69 |
| EPS | ★ 14.73 | 7.68 |
| Revenue | ★ $199,125,000,000.00 | $8,777,845,000.00 |
| Revenue This Year | N/A | $10.97 |
| Revenue Next Year | $3.07 | $7.36 |
| P/E Ratio | ★ $27.33 | $38.15 |
| Revenue Growth | ★ 12.49 | N/A |
| 52 Week Low | $274.89 | $232.10 |
| 52 Week High | $436.24 | $366.50 |
| Indicator | ELV | RCL |
|---|---|---|
| Relative Strength Index (RSI) | 54.19 | 41.52 |
| Support Level | $382.77 | $278.01 |
| Resistance Level | $406.36 | $295.69 |
| Average True Range (ATR) | 8.42 | 7.24 |
| MACD | 1.25 | -2.94 |
| Stochastic Oscillator | 65.91 | 20.57 |
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
Royal Caribbean is the world's second-largest cruise company by revenues, operating 71 ships across five global and partner brands in the cruise vacation industry. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises. The selection of brands in the portfolio allows Royal to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in 2021, plans to launch its new Celebrity River Cruise brand in 2027, and is set to operate eight private destination locations by 2028.